Nikkomycin Z for the treatment of experimental sporotrichosis caused by Sporothrix brasiliensis
Mycoses · 2023
DOI: 10.1111/myc.13629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, 2023. Verfasst von Vanice Rodrigues Poester und 7 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-Graduação em Ciências da Saúde, Faculdade de Medicina (FAMED), Universidade Federal do Rio Grande (FURG), Rio Grande, Brazil. Hauptthemen laut MEDLINE: Sporotrichosis, Sporothrix. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul.
Abstract (Originalsprache)
Sporotrichosis caused by Sporothrix brasiliensis is a global emergent infectious disease. Due to the scarcity of therapeutic options for fungal diseases, new antifungals are urgently needed. Nikkomycin Z (NikZ) is a future option as an agent against dimorphic fungi. We evaluated NikZ monotherapy and in combination with itraconazole (ITZ; the conventional therapy) in the treatment of experimental sporotrichosis caused by S. brasiliensis in a murine model. Animals were subcutaneously infected, and treated orally for 30 days. The study groups were as follows control (untreated), ITZ group (50 mg/kg/day), and three groups treated with NikZ, two by monotherapy (200 or 400 mg/kg/day), and one combining NikZ (400 mg/kg/day) and ITZ. Efficacy of treatments was evaluated via body weight gain, mortality and fungal burden in tissues. Efficacy was noted in all treatment groups, and the group receiving the drug combination showed even better results than those with monotherapy. Our study shows for the first time the high potential of NikZ to be used in the treatment of sporotrichosis caused by S. brasiliensis .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Programa de Pós-Graduação em Ciências da Saúde, Faculdade de Medicina (FAMED), Universidade Federal do Rio Grande (FURG), Rio Grande, Brazil.
- Mycology Laboratory of FAMED-FURG, Rio Grande, Brazil.
- California Institute for Medical Research, San Jose, California, USA.
- Division of Infectious Diseases and Geographic Medicine, Stanford University Medical School, Stanford, California, USA.
- Department of Infectious Diseases, National Institute of Health Doutor Ricardo Joge, Lisbon, Portugal.
- Universidade Federal de Santa Maria (UFSM), Santa Maria, Brazil.
ORCID-Profile: Vanice Rodrigues Poester, Lívia Silveira Munhoz, Aryse Martins Melo, Mariana Rodrigues Trápaga
Förderung
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
Zitieren
APA
Poester, V. R., Munhoz, L. S., Stevens, D. A., Melo, A. M., Trápaga, M. R., Flores, M. M., Larwood, D. J., & Xavier, M. O. (2023). Nikkomycin Z for the treatment of experimental sporotrichosis caused by Sporothrix brasiliensis. Mycoses. https://doi.org/10.1111/myc.13629
Vancouver
Poester VR, Munhoz LS, Stevens DA, Melo AM, Trápaga MR, Flores MM, et al. Nikkomycin Z for the treatment of experimental sporotrichosis caused by Sporothrix brasiliensis. Mycoses. 2023. doi:10.1111/myc.13629
BibTeX
@article{Poester2023,
author = {Poester, Vanice Rodrigues and Munhoz, Lívia Silveira and Stevens, David A and Melo, Aryse Martins and Trápaga, Mariana Rodrigues and Flores, Mariana Martins and Larwood, David J and Xavier, Melissa Orzechowski},
title = {Nikkomycin Z for the treatment of experimental sporotrichosis caused by Sporothrix brasiliensis},
journal = {Mycoses},
year = {2023},
doi = {10.1111/myc.13629}
}
EUVIMED